← Evidence map

TrialAdvances in therapy2020

Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.

David J Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 31836949